| |
| |
|
| Insider
Information: |
Ronsheim Matthew |
| Relationship: |
See Remarks |
| City: |
Waltham |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
40,778 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$622,272 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
40,778 |
|
|
| Total
Value |
$622,272 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Entasis Therapeutics Holdings Inc. |
ETTX |
Chief of Pharma Scienc... |
2022-07-11 |
0 |
2021-01-15 |
0 |
Premium* |
|
|
Innoviva Inc |
INVA |
See Remarks |
2024-03-05 |
40,778 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| INVA |
Innoviva Inc |
See Remarks |
• – – |
2024-03-05 |
4 |
A |
$14.88 |
$189,988 |
D/D |
12,768 |
40,778 |
0 |
- |
|
| INVA |
Innoviva Inc |
See Remarks |
• – – |
2024-02-20 |
4 |
D |
$15.80 |
$12,751 |
D/D |
(807) |
28,010 |
0 |
- |
|
| INVA |
Innoviva Inc |
See Remarks |
• • – |
2024-01-18 |
4 |
D |
$16.05 |
$25,680 |
D/D |
(1,600) |
28,817 |
0 |
- |
|
| INVA |
Innoviva Inc |
See RemarksOfficer |
• – – |
2024-01-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
12,945 |
|
% |
|
| ETTX |
Entasis Therapeutics Hold... |
Chief of Pharma Sciences & MFG |
• – – |
2022-07-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(150,000) |
0 |
0 |
- |
|
| ETTX |
Entasis Therapeutics Hold... |
Chief of Pharma Sciences & MFG |
• – – |
2022-07-07 |
4 |
D |
$2.20 |
$38,658 |
D/D |
(17,572) |
0 |
0 |
- |
|
| ETTX |
Entasis Therapeutics Hold... |
See Remarks |
• – – |
2022-01-18 |
4 |
A |
$0.00 |
$0 |
D/D |
125,000 |
167,572 |
0 |
- |
|
| ETTX |
Entasis Therapeutics Hold... |
Chief, Pharma Sciences & MFG. |
• – – |
2021-11-02 |
4 |
D |
$2.94 |
$10,787 |
D/D |
(3,669) |
42,572 |
0 |
- |
|
| ETTX |
Entasis Therapeutics Hold... |
See Remarks |
• – – |
2021-10-19 |
4 |
S |
$3.19 |
$11,991 |
D/D |
(3,759) |
46,241 |
0 |
% |
|
| ETTX |
Entasis Therapeutics Hold... |
See Remarks |
• – – |
2021-10-19 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
50,000 |
0 |
- |
|
| ETTX |
Entasis Therapeutics Hold... |
See Remarks |
• – – |
2021-01-15 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
0 |
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
